Ethylmethylthiambutene

Ethylmethylthiambutene (N-ethyl-N-methyl-1-methyl-3,3-di-2-thienylallylamine; Emethibutin) is an opioid analgesic drug from the thiambutene family, around 1.3x the potency of morphine.^[2][3][4] It is under international control under Schedule I of the UN Single Convention On Narcotic Drugs 1961, presumably due to high abuse potential.

Ethylmethylthiambutene

Clinical data
ATC code	none
Legal status
Legal status	BR: Class A1 (Narcotic drugs)[1] CA: Schedule I DE: Anlage I (Authorized scientific use only) US: Schedule I
Identifiers
IUPAC name N-ethyl-N-methyl-4,4-dithiophen-2-yl-but-3-en-2-amine
CAS Number	441-61-2
PubChem CID	46424
DrugBank	DB01468 Y
ChemSpider	42256 Y
UNII	722BFZ899Q
KEGG	D12663 Y
CompTox Dashboard (EPA)	DTXSID60861937
ECHA InfoCard	100.006.482
Chemical and physical data
Formula	C15H19NS2
Molar mass	277.44 g·mol−1
3D model (JSmol)	Interactive image
SMILES CCN(C)C(C)C=C(C1=CC=CS1)C2=CC=CS2
InChI InChI=1S/C15H19NS2/c1-4-16(3)12(2)11-13(14-7-5-9-17-14)15-8-6-10-18-15/h5-12H,4H2,1-3H3 Y Key:MORSAEFGQPDBKM-UHFFFAOYSA-N Y
(verify)

It is a Schedule I controlled substance in the United States with a DEA ACSCN of 9623 and zero annual manufacturing quota as of 2013.^{[citation needed]}